Date | Speaker(s) | Presentation Title |
---|---|---|
February 2016 | John F. McDonald, Ph.D. |
An Integrated Approach to Ovarian Cancer Diagnostics and Personalized Therapy |
February 2016 | Susan T. Mayne, Ph.D., F.A.C.E. |
FDA's Role in Translating Science for Improved Public Health/Cancer Prevention |
January 2016 | Melissa Troester, Ph.D., M.P.H. |
Landscape of Normal Breast and Breast Cancer |
December 2015 | Norma Fox Kanarek, Ph.D., M.P.H. |
State Cancer Plans, Cancer Centers and Population Health: Tools or Toolbox? |
December 2015 | Corinne Husten, M.D., M.P.H. |
The FDA Center for Tobacco Products: Its Role in Reducing Tobacco Use and How Regulatory Science Informs Action |
October 2015 | Kathryn Weaver, Ph.D., M.P.H. |
Integrating Tobacco Cessation in the Oncology Setting |
October 2015 | Gwen Murphy, Ph.D., M.P.H. |
GI Hormones and Cancer: The Good, The Bad, and The Cholecystokinin |
October 2015 | Dominique S. Michaud, Sc.D. |
Oral Microbiome and Pancreatic Cancer |
October 2015 | Worta McCaskill-Stevens, M.D., M.S. & Ann M. Geiger, Ph.D., M.P.H. |
Opportunities in Cancer Care Delivery Research |
June 2015 | Martin Lajous, M.D., M.S., D.Sc. |
The Mexican Teachers’ Cohort: Bridging a Population Research Gap |